Cosmo Feilding Mellen

Co-founder, Beckley Psytech; AtaiBeckley board member

Appears in 1 story

Last updated Jul 17, 2026

Stories

Eli Lilly buys psychedelic drugmaker AtaiBeckley

Money Moves

As of July 2026: On the board of the company being sold

Eli Lilly agreed to buy AtaiBeckley for $6.75 a share in cash, about $2.8 billion, with up to $1 billion more if two drugs hit development targets. The purchase pulls one of the world's largest drugmakers into psychedelic medicine.

Updated Jul 16